Table 2.
ALS | Ctrl | |||||
---|---|---|---|---|---|---|
miRNA/gene | ΔCtmin | ΔCtmax | Median ΔCt | ΔCtmin | ΔCtmax | Median ΔCt |
let-7b | 0.65 | 3.79 | 2.32 | 3.68 | 8.69 | 5.93 |
miR-9 | 7.13 | 10.9 | 8.95 | 9.27 | 19.72 | 12.74 |
miR-124a | 7.69 | 10.11 | 8.82 | 21.40 | 28.93 | 24.50 |
miR-132 | 5.66 | 8.69 | 6.68 | 6.33 | 12.19 | 8.85 |
miR-143 | 5.39 | 13.81 | 10.12 | 5.96 | 13.73 | 9.84 |
miR-206 | 10.60 | 16.39 | 11.65 | 12.59 | 18.66 | 15.94 |
miR-338 | 3.82 | 9.50 | 7.98 | 4.41 | 14.38 | 9.90 |
miR-451a | −1.00 | 5.23 | 2.43 | 1.34 | 8.26 | 4.46 |
miR-638 | 1.16 | 4.05 | 2.76 | 4.76 | 9.02 | 6.65 |
miR-663a | 1.47 | 3.48 | 2.38 | 2.10 | 6.81 | 4.36 |
DNM2 | 6.97 | 10.56 | 8.76 | 1.63 | 7.32 | 4.86 |
AATK | 6.08 | 11.25 | 9.47 | −0.89 | 15.50 | 12.07 |
ALS, amyotrophic lateral sclerosis patients; Ctrl, controls; Ct, threshold cycle; ΔCt, delta Ct; ΔCtmin, minimal ΔCt detected within a group; ΔCtmax, maximal ΔCt detected within a group; median ΔCt, median of all individual detected ΔCts between maximal and minimal ΔCts within the group of patients/controls.